| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 413,284 | 454,446 | 495,819 | 566,059 | | Cost of Revenue |
-
|
-
| (168,599) | 168,599 | | | Gross Profit |
-
| 454,446 | 664,418 | 397,460 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 68,862 | 63,926 | 244,877 | (84,255) | | Non Recurring | (37) | 1,382 | 7,810 | 2,104 | | Others | 168,061 | 185,793 | 248,510 | 300,179 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 203,345 | 163,221 | 179,432 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 176,398 | 203,345 | 163,221 | 179,432 | | Interest Expense |
-
| 147,426 | 143,085 | 219,063 | | Income Before Tax | 46,250 | 55,919 | 20,136 | (39,631) | | Income Tax Expense | 20,489 | 24,647 | 10,303 | (14,075) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 25,761 | 31,272 | 9,833 | (25,556) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 25,761 | 31,272 | 9,833 | (25,556) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $25,761 | $31,272 | $9,833 | ($25,556) |
|
0.08% Nasdaq 
0.32%
Income Statement
